3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Hematologic Neoplasms
2
COVID-19
2
Skin Neoplasms
1
Respiratory Sounds
1
Respiratory Distress Syndrome
1
Pneumonia, Viral
1
Pharmacokinetics
1
Neoplasms
1
Lymphoma, Follicular
1
Cytokine Release Syndrome
1
Crohn Disease
1
Bronchiolitis Obliterans Syndrome
1
Asthma
1
Adenomatous Polyposis Coli
1
Interventions
Fluticasone-Salmeterol Drug Combination
3
Etanercept
3
Fluticasone
2
Budesonide
2
Beclomethasone
2
perflutren
1
laninamivir
1
fluticasone-formoterol
1
Sulfur Hexafluoride
1
Prednisolone
1
NVP-QAV680
1
Lysine Acetyltransferase 5
1
Health Information Exchange
1
Formoterol Fumarate
1
Exercise
1
Escitalopram
1
CS 8958
1
Budesonide, Formoterol Fumarate Drug Combination
1
Bronchial Thermoplasty
1
Blood Specimen Collection
1
Azithromycin
1
Amoxicillin-Potassium Clavulanate Combination
1
Albuterol
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Asthma
×
Azithromycin
×
Clear all
NCT02517099
2023-03-06
PrIGMa
Imperial College London
Phase 2
Completed
60 enrolled
10 charts